19
Views
2
CrossRef citations to date
0
Altmetric
Symposium: Patching, Drugs, or Lasik? Amblyopia Treatment in the 21st Century

Current Recommendations for Amblyopia Treatment

, C.O., C.O.M.T.
Pages 60-67 | Published online: 22 Dec 2017

References

  • Clarke MP, Wright CM, Hrisos S: Randomized controlled trial of treatment of unilateral visual impairment detected at preschool vision screening. BMJ 2003; 327: 1251–1254.
  • PPEDIG: The course of moderate amblyopia treated with patching in children: Experience of the amblyopia treatment study. Am J Ophthalmol 2003; 136: 620–629.
  • Williams C, Northstone K, Harrad R: Amblyopia treatment outcomes after screening before 3 years vs. at 3 years of age: Follow-up from a randomized trial. BMJ 2002; 324: 1549–1551.
  • Loudon SE, Polling JR, Simonsz HJ: A preliminary report about the relation between visual acuity increase and compliance in patching therapy for amblyopia. Strabismus 2002; 10: 79–82.
  • Loudon SE, Polling JR, Simonsz HJ: Electronically measured compliance with occlusion therapy for amblyopia is related to visual acuity increase. Graefes Arch Clin Exp Ophthalmol 2003: 241: 176–180.
  • Dorey SE, Adams GG, Lee JP, Sloper JJ: Intensive occlusion therapy for amblyopia. Br J Ophthalmol 2001; 85: 310–313.
  • Joslin CE, McMahon TT, Kaufman LM: The effectiveness of occluder contact lenses in improving occlusion compliance in patients that have failed traditional occlusion therapy. Optom Vis Sci 2002; 79: 376–380.
  • Dixon-Woods M, Awan M, Gottlob I: Why is compliance with occlusion therapy for amblyopia so hard? A qualitative study. Arch Dis Child 2006; 91: 491–494.
  • Hrisos S, Clarke MP, Wright CM: The emotional impact of amblyopia treatment in preschool children: Randomized controlled trial. Ophthalmology 2004; 111: 1550–1556.
  • Holmes JM, Beck RW, Kraker RT, Cole SR, Repka MX, Birch EE, Felius J, Christiansen SP, Coats DK, Kulp MT, PEDIG: Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. Arch Ophthalmol 2003; 121: 1625–1632.
  • Newsham DA: Parental non-concordance with occlusion therapy. Br J Ophthalmol 2000; 84: 957–962.
  • Searle A, Norman P, Harrad R, Bedhara K: Psychosocial and clinical determinants of compliance with occlusion therapy for amblyopic children. Eye 2002; 16: 150–155.
  • Oto S, Pelit A, Aydin P: Non-concordance in amblyopia treatment: The effective use of ‘smileys’. Strabismus 2002; 10: 23–30.
  • Stewart CE, Moseley MJ, Stephens DA, Fielder AR: Treatment dose-response in amblyopia therapy: The Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Invest Ophthalmol Vis Sci 2004; 45: 3048–3054.
  • Oliver M, Neumann R, Chaimovitch Y: Complaince and results of treatment for amblyopia in children more than 8 years old. Am J Ophthalmol 1986; 102: 340–345.
  • Smith LK, Thompson JR, Woodruff G: Factors affecting treatment compliance in amblyopia. J Pediatr Ophthalmol Strabismus 1985; 32: 98–101.
  • Chua BE, Johnson K, Martin F: A retrospective review of the associations between amblyopia type, patient age, treatment compliance, and referral patterns. Clin Experiment Ophthalmol 2004; 32: 175–179.
  • Stewart CE, Moseley MJ, Stephens DA, Fielder AR, ROTAS Cooperative: Modeling of treatment dose-response in amblyopia. Invest Ophthalmol Vis Sci 2005b; 46: 3595.
  • Awan M, Proudlock FA, Gottlob I: A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci 2005; 46: 1435–1439.
  • Fielder AR, Auld R, Irwin M: Complaince monitoring in amblyopia therapy. Lancet 1994; 343: 547.
  • Loudon SE, Verhoef BL, Joosse MV: Electornic recoriding of patching for amblyopia study (ERPAS): Preliminary results. Invest Ophthalmol Vis Sci 2003; 44: 4246.
  • Loudon SE, Simonsz B, Josse MV: Electronic recording of patching for amblyopia predictors for non-compliance. Invest Ophthalmol Vis Sci 2004; 45: 4991.
  • Horwood J, Waylen A, Herrick D, Williams C, Wolke D: Common visual defects and peer victimization in children. Invest Ophthalmol Vis Sci 2005; 46: 1177–1181.
  • Newsham D: A randomized controlled trial of written information: The effect on parental non-concordance with occlusion therapy. Br J Ophthalmol 2002; 86: 787–791.
  • Tripathi A, O'Donnell NP, Holden R, Kaye L, Kaye SB: Occlusion therapy for the treatment of amblyopia: Letting the parents decide. Ophthalmologica 2002; 216: 426–429.
  • Anderson JE, Brown SM, Mathews TA, Mathews SM: Opaque contact lens treatment for older children with amblyopia. Eye Contact Lens 2006; 32: 84–87.
  • Eastgate RM, Griffiths GD, Waddingham PE, Moody AD, Butler TK, Cobb SV, Comaish IF, Haworth SM, Gregson RM, Ash IM, Brown SM: Modified virtual reality technology for treatment of amblyopia. Eye 2006; 20: 370–374.
  • Kampf U, Muchamedjarow F, Seiler T: Supportive amblyopia treatment by means of computer games with background stimulation: A placebo controlled pilot study of 10 days. Klin Monatsbl Augenheilkd 2001; 218: 243–250.
  • Waddington PE, Butler TK, Cobb SV, Moody AD, Comaish IF, Haworth SM, Gregson RM, Ash IM, Brown SM, Eastgate RM, Griffiths GD: Preliminary results from the use of the novel Interactive binocular treatment (I-BiT) system, in the treatment of strabismic and anisometropic amblypopia. Eye 2006; 20: 375–378.
  • Fronius M, Cirina L, Cordey A, Ohrloff C: Visual improvement during psychophysical training in an adult amblyopic eye following visual loss in the contralateral eye. Graefes Arch Clin Exp Ophthalmol 2005; 243: 278–280.
  • Subharngkasen I: Successful amblyopia therapy by using synoptophore. J Med Assoc Thai 2003; 86: S556–S562.
  • Holmes JM, Edwards AR, Beck RW, Arnold RW, Johnson DA, Klimek DL, Kraker RT, Lee KA, Lyon DW, Nosel ER, Repka MX, Sala NA, Silbert DI, Tamkins S, PEDIG: A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia. J AAPOS 2005; 9: 129–136.
  • Bhartiya P, Sharma P, Biswas NR, Tandon R, Khokhar SK: Levodopa-carbidopa with occlusion in older children with amblyopia. J AAPOS 2002; 6: 368–372.
  • Leguire LE, Komaromy KL, Nairus TM, Rogers GL: Long-term follow-up of L-dopa treatment in children with amblyopia. J Pediatr Ophthalmol Strabismus 2002; 39: 326–330.
  • Leguire LE, Rogers GL, Walson PD, Bremer DL, McGregor ML: Occlusion and Levodopa-carbidopa treatment for childhood amblyopia. J AAPOS 1998; 2: 257–264.
  • Pandey PK, Chaudhuri Z, Kumar M, Satyabala K, Sharma P: Effect of Levodopa and carbidopa in human amblyopia. J Pediatr Ophthalmol Strabismus 2002; 39: 81–89.
  • France TD, France LW: Optical penalization can improve vision after occlusion treatment. J AAPOS 1999; 3: 341–343.
  • Iacobucci IL, Archer SM, Furr BA, Martonyi JB, Del Monte MA: Bangerter foils in the treatment of moderate amblyopia. Am Orthopt J 2001; 51: 84–91.
  • Min BM, Kim SY, DO KH, Lee SB: A comparison of Min's glasses and conventional occlusion therapy in the treatment of amblyopic children: A prospective study. Korean J Ophthalmol 2000; 14: 32–37.
  • Repka MX, Cotter SA, Beck RW, Kraker RT, Birch EE, Everett DF, Hertle RW, Holmes JM, Quinn GE, Sala NA, Scheiman MM, Stager DR Sr, Wallace DK, PEDIG: A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology 2004; 111: 2076–2085.
  • PEDIG: The course of moderate amblyopia treated with atropine in children: Experience of the amblyopia treatment study. Am J Ophthalmol 2003; 136: 630–639.
  • PPEDIG: A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors. Ophthalmology 2003; 110: 1632–1637.
  • Kaye SB, Chen SI, Price G, Kaye LC, Noonan C, Tripathi A, Ashwin P, Coat N, Clark D, Butcher J: Combined optical and atropine penalization for the treatment of strabismic and anisometropic amblyopia. J AAPOS 2002; 6: 289–293.
  • PPEDIG: A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2002; 120: 268–278.
  • Repka MX, Wallace DK, Beck RW, Kraker RT, Birch EE, Cotter SA, Donahue S, Everett DF, Hertle RW, Holmes JM, Quinn GE, Scheiman MM, Weakley DR, PEDIG: Two-year follow-up of a 6-month randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2005; 123: 149–157.
  • Scott WE, Kutschke PJ, Keech RV, Pfeifer WL, Nichols B, Zhang L: Amblyopia treatment outcomes. J AAPOS 2005; 9: 107–111.
  • Hug T: Full-time occlusion compared to part-time occlusion for the treatment of amblyopia. Optometry 2004; 75: 241–244.
  • Repka MS, Beck RW, Holmes JM, Birch EE, Chandler DL, Cotter SA, Hertle RW, Kraker RT, Moke PS, Quinn GE, Scheiman MM, PEDIG: A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol 2003; 121: 603–611.
  • Holmes JM, Kraker RT, Beck RW, Birch EE, Cotter SA, Everett DF, Hertle RW, Quinn GE, Repka MX, Scheiman MM, Wallace DK, PEDIG: A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology 2003; 220: 2075–2087.
  • Stewart CE, Fielder AR, Stephens DA, Moseley MJ: Treatment of unilateral amblyopia: Factors influencing visual outcome. Invest Ophthalmol Vis Sci 2005; 46: 3152–3160.
  • Arikan G Yaman A, Berk AT: Efficacy of occlusion treatment in amblyopia and clinical risk factors affecting the results of treatment. Strabismus 2005; 13: 63–69.
  • Flynn JT, Woodruff G, Thompson JR, Hiscox F, Feuer W, Schiffman J, Corona A, Smith LK: The therapy of amblyopia: An analysis comparing the results of amblyopia therapy utilizing two pooled data sets. Trans Am Ophthalmol Soc 1999; 97: 373–390.
  • Simons K: Amblyopia characterization, treatment, and prophylaxis: Surv Ophthalmol 2005; 50: 123–166.
  • El Mallah MK, Chakravarthy U, Hart PM: Amblyopia: Is visual loss permanent? Br J Ophthalmol 2000; 84: 952–956.
  • Chua B, Mitchell P: Consequences of amblyopia on education, occupation, and long term vision loss. Br J Ophthalmol 2004; 88: 1119–1121.
  • Rahi JS, Logan S, Borja MC, Timms C, Russell-Eggitt I, Taylor D: Prediction of improved vision in the amblyopic eye after visual loss in the non-amblyopic eye. Lancet 2002; 360: 621–622.
  • Wu C, Hunter DG: Amblyopia: Diagnostic and therapeutic options. Am J Ophthalmol 2006; 141: 175–184.
  • PPEDIG: Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol 2005b; 123: 437–447.
  • Park KH, Hwang JM, Ahn JK: Efficacy of amblyopia therapy initiated after 9 years of age. Eye 2004; 18: 571–574.
  • Mohan K, Saroha V, Sharma A: Successful occlusion therapy for amblyopia in 11- to 15-year old children. J Pediatr Ophthalmol Strabismus 2004; 41: 89–95.
  • Chen JP, Song WX, Wu QH: Clinical study of visual plasticity in teenage and adults with amblyopia. Zhonghua Yan Ke Za Zhi 2003; 39: 710–713.
  • Mintz-Hittner HA, Fernandez KM: Successful amblyopia therapy initiated after age 7 years: Compliance cures. Arch Ophthalmol 2000; 119: 1226.
  • Cleary M: Efficacy of occlusion for strabismic amblyopia: Can an optimal duration be identified? Br J Ophthalmol 2000; 84: 572–578.
  • Keech RV, Ottar W, Zhang L: The minimum occlusion trial for the treatment of amblyopia. Ophthalmology 2002; 109: 2261–2264.
  • Leiba H, Shimshoni M, Oliver M, Gottesman N, Levartovsky S: Long-term follow-up of occlusion therapy in amblyopia. Ophthalmology 2001; 108: 1552–1555.
  • Ohlsson J, Baumann M, Sjostrand J, Abrahamsson M: Long term visual outcome in amblyopia treatment. Br J Ophthalmol 2002; 86: 1148–1151.
  • Rutstein RP, Corliss DA: Long-term changes in visual acuity and refractive error in amblyopes. Optom Vis Sci 2004; 81: 510–515.
  • Holmes JM, Beck RW, Kraker RT, Astle WF, Birch EE, Cole SR, Cotter SA, Donahue S, Everett DF, Hertle RW, Keech RV, Paysse E, Quinn GF, Repka MX, Scheiman MM, PEDIG: Risk of amblyopia recurrence after cessation of treatment. J AAPOS 2004; 8: 420–428.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.